Image provided by Novalix

François Debaene profile page

Head of Mass Spectrometry

at Novalix

François Debaene is Head of Mass Spectrometry at Novalix, a position he has held for 7 years. With over 15 years of expertise in mass spectrometry (MS), particularly structural MS, he has supported numerous drug discovery projects in the biopharmaceutical and CRO sectors. He obtained his PhD at the University of Strasbourg on PNA-encoded library, followed by postdoctoral work in structural MS at LSMBO/CNRS and a position at Sanofi Paris as Deputy Head of the Structural Analysis Laboratory. Since 2017, François has built and led the MS team at Novalix, implementing advanced approaches surch as HDX-MS and SEC-UV-native MS for structural studies, as well as covalent and non-covalent screening approaches, including binding site identification for soluble or membrane proteins. He has authored over 40 publications and oral communications, and currently manages a team of six scientists and three dedicated MS systems.

Got a Question for François Debaene?

Get in touch using the contact form linked here and we'll get back to you shortly.

Content Written By, Reviewed By, or Featuring François Debaene

Total: 1

Webinar

Mass Spectrometry in Drug Discovery: Covalent and Non-Covalent Screening Applications

On-Demand

In this webinar, Dr. Johann Stojko, experienced biophysicist at Novalix, will present integrated workflows that combine covalent fragment screening and non-covalent binder detection to support hit discovery and validation.